Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atypical Mycobacterium Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT04921943
What this trial is testing

Hypertonic Saline for MAC

Who this might be right for
Nontuberculous Mycobacterial Lung DiseaseNontuberculous Mycobacterium Infection
Oregon Health and Science University 50
Not applicableEnded earlyNCT00999076
What this trial is testing

Rapid Identification of Mycobacteria in Acid-fast Bacilli Smear-positive Respiratory Specimens

Who this might be right for
Atypical MycobacteriaMycobacterium Infections
Samsung Medical Center 200
Not applicableStudy completedNCT00002085
What this trial is testing

Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV InfectionsTuberculosis, Mycobacterium Infection
Pfizer
Not applicableLooking for participantsNCT06155747
What this trial is testing

Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)

Who this might be right for
Nontuberculous Mycobacterial Pulmonary InfectionOutbreak InvestigationHealthcare Associated Infection+1 more
University of North Carolina, Chapel Hill 100
Large-scale testing (Phase 3)Ended earlyNCT06418711
What this trial is testing

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Who this might be right for
MAC Lung DiseaseTreatment Refractory MAC Lung DiseaseMycobacterium Infections, Nontuberculous
Mannkind Corporation 132